SecurityVONG / Vanguard Russell 1000 Growth ETF (92206C680)
Institutional Owners116
Institutional Shares5,304,952
Institutional Value$ 918,564,000 USD
Related VCIT / Vanguard Intermediate-Term Corporate Bond Index Fund
VGIT / Vanguard Intermediate-Term Government Bond Index Fund
VCLT / Vanguard Long-Term Corporate Bond Index Fund
VGLT / Vanguard Long-Term Government Bond Index Fund
VMBS / Vanguard Mortgage-Backed Securities Index Fund
VONE / Vanguard Russell 1000 ETF
VONV / Vanguard Russell 1000 Value ETF
VTWO / Vanguard Russell 2000 ETF
VTWG / Vanguard Russell 2000 Growth ETF
VTWV / Vanguard Russell 2000 Value ETF
VTHR / Vanguard Russell 3000 ETF
VCSH / Vanguard Short-Term Corporate Bond Index Fund
VGSH / Vanguard Short-Term Government Bond Index Fund

Institutional Stock Ownership and Shareholders

VONG / Vanguard Russell 1000 Growth ETF Institutional Ownership

Vanguard Russell 1000 Growth ETF (NASDAQ:VONG) has 116 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,304,952 shares. Largest shareholders include Bank Of America Corp /de/, Suntrust Banks Inc, UBS Group AG, Wells Fargo & Company/mn, Janney Montgomery Scott LLC, Morgan Stanley, Sequoia Financial Advisors, LLC, LPL Financial LLC, Hapanowicz & Associates Financial Services, Inc, and Comerica Bank.
Vanguard Russell 1000 Growth ETF (NASDAQ:VONG) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-31 13F-HR Chicago Partners Investment Group LLC 985 145
2018-08-01 13F-HR SONATA CAPITAL GROUP INC 3,502 3,202 -8.57 489 471 -3.68
2018-07-27 13F-HR Eqis Capital Management, Inc. 14,725 22,471 52.60 2,057 3,304 60.62
2018-08-14 13F-HR UBS Group AG 467,508 438,847 -6.13 65,306 64,519 -1.21
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 4,621 1,787 -61.33 646 263 -59.29
2018-08-10 13F-HR STEPHENS INC /AR/ 9,535 1,402
2018-08-14 13F-HR ROYAL BANK OF CANADA 84,037 88,421 5.22 11,739 13,000 10.74
2018-07-24 13F-HR Janney Montgomery Scott LLC 394,902 405,359 2.65 55,164 59,596 8.03
2018-08-10 13F-HR WASHINGTON TRUST Co 365 54
2018-08-14 13F-HR COLONY GROUP LLC 48,003 48,051 0.10 6,706 7,064 5.34
2018-08-10 13F-HR OPPENHEIMER & CO INC 2,200 2,200 0.00 307 323 5.21
2018-08-10 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 63 63 0.00 9 9 0.00
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 87,656 87,465 -0.22 10,661 11,221 5.25
2018-07-09 13F-HR Nadler Financial Group, Inc. 87,240 12,826
2018-08-20 13F-HR CITY HOLDING CO 183 183 0.00 26 27 3.85
2018-08-14 13F-HR MACQUARIE GROUP LTD 5,420 4,715 -13.01 756 693 -8.33
2018-08-13 13F-HR Sws Partners 100 0 -100.00 14 0 -100.00
2018-08-14 13F-HR FIFTH THIRD BANCORP 924 650 -29.65 129 96 -25.58
2018-05-15 13F-HR National Asset Management, Inc. 2,804 3,824 36.38 387 535 38.24
2018-08-13 13F-HR Advisor Group, Inc. 7,098 7,125 0.38 991 1,047 5.65
2018-05-04 13F-HR Financial Gravity Companies, Inc. 64 9
2018-08-08 13F-HR Private Capital Group, Llc 11,897 11,794 -0.87 1,662 1,739 4.63
2018-08-14 13F-HR UNITED CAPITAL FINANCIAL ADVISERS, LLC 2,211 0 -100.00 309 0 -100.00
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 1,482 1,916 29.28 207 282 36.23
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-08-10 13F-HR Amerivest Investment Management LLC 11,356 1,670
2018-08-10 13F-HR PATHSTONE FAMILY OFFICE, LLC 1,472 990 -32.74 206 146 -29.13
2018-08-14 13F-HR Delta Dental Plan of Michigan, Inc. 21,632 21,632 0.00 3,022 3,180 5.23
2018-07-13 13F-HR ATRIA INVESTMENTS LLC 1,871 275
2018-08-13 13F-HR Renaissance Technologies LLC 2,300 2,300 0.00 321 321 0.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 35,990 13,097 -63.61 5,021 1,926 -61.64
2018-08-07 13F-HR TRUST CO OF VIRGINIA /VA 1,495 1,995 33.44 209 293 40.19
2018-07-17 13F-HR CALAMOS WEALTH MANAGEMENT LLC 1,488 1,488 0.00 208 219 5.29
2018-08-14 13F-HR Gryphon Financial Partners Llc 207 232 12.08 29 34 17.24
2018-08-13 13F-HR COMERICA SECURITIES INC 12,538 13,487 7.57 1,751 1,989 13.59
2018-08-15 13F-HR JANE STREET GROUP, LLC 42,408 62,506 47.39 5,924 9,190 55.13
2018-08-01 13F-HR COMERICA BANK 117,601 113,359 -3.61 16,788 17,416 3.74
2018-08-13 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 10,101 5,268 -47.85 1,411 775 -45.07
2018-07-19 13F-HR Hapanowicz & Associates Financial Services, Inc 136,749 136,490 -0.19 18,621 20,178 8.36
2018-07-27 13F-HR PINNACLE FINANCIAL PARTNERS INC 3,535 4,804 35.90 494 706 42.91
2018-07-30 13F-HR Parallel Advisors, LLC 97 14
2018-08-14 13F-HR LPL Financial LLC 225,964 230,898 2.18 31,565 33,947 7.55
2018-08-14 13F-HR JP Morgan Chase & Co 263 263 0.00 37 39 5.41
2018-08-08 13F-HR First Allied Advisory Services, Inc. 2,117 1,958 -7.51 296 288 -2.70
2018-08-13 13F-HR RBO & CO LLC 3,000 441
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 407,038 408,493 0.36 56,860 60,057 5.62
2018-08-14 13F-HR Balentine LLC 18,742 18,364 -2.02 2,618 2,700 3.13
2018-08-13 13F-HR IHT Wealth Management, LLC 132 0 -100.00 18 0 -100.00
2018-08-10 13F-HR Opus Capital Group, LLC 15,320 14,303 -6.64 2,140 2,103 -1.73
2018-08-13 13F-HR BB&T SECURITIES, LLC 4,404 2,678 -39.19 615 393 -36.10
2018-08-13 13F-HR Wealthcare Advisory Partners LLC 200 520 160.00 28 76 171.43
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 18,742 18,364 -2.02 2,618 2,700 3.13
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 0 8,093 0 1,190
2018-08-14 13F-HR Financial Gravity Wealth, Inc. 64 70 9.38 9 11 22.22
2018-08-10 13F-HR Cambridge Investment Research Advisors, Inc. 3,103 3,423 10.31 434 503 15.90
2018-05-11 13F-HR CITIGROUP INC 775 775 0.00 107 108 0.93
2018-08-09 13F-HR Private Advisor Group, LLC 2,868 0 -100.00 401 0 -100.00
2018-04-16 13F-HR IFC Holdings Incorporated/FL 7,643 0 -100.00 1,058 0 -100.00
2018-07-17 13F-HR Winslow, Evans & Crocker, Inc. 66 66 0.00 9,080 10 -99.89
2018-08-09 13F-HR/A Integrated Investment Consultants, LLC 7,578 7,507 -0.94 1,059 1,104 4.25
2018-08-13 13F-HR Asset Dedication, LLC 416 61
2018-08-09 13F-HR Sawtooth Asset Management, Inc. 11,389 1,675
2018-08-03 13F-HR Financial Architects, Inc 352 352 0.00 49 52 6.12
2018-07-18 13F-HR Prospera Financial Services 13,895 13,960 0.47 1,940 2,070 6.70
2018-08-22 13F-HR McAdam, LLC 33 33 0.00 5 5 0.00
2018-08-14 13F-HR SILVERCREST ASSET MANAGEMENT GROUP LLC 53,670 56,670 5.59 7,497 8,332 11.14
2018-08-14 13F-HR Cetera Advisor Networks LLC 44,857 0 -100.00 6,258 0 -100.00
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 49,219 54,955 11.65 6,875 8,079 17.51
2018-08-13 13F-HR Baird Financial Group, Inc. 64,459 64,015 -0.69 9,004 9,411 4.52
2018-08-10 13F-HR CITIGROUP INC 775 775 0.00 108 114 5.56
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 798,284 878,344 10.03 111,513 129,135 15.80
2018-08-13 13F-HR RAYMOND JAMES & ASSOCIATES 9,560 17,916 87.41 1,335 2,634 97.30
2018-07-11 13F-HR TRUST CO OF VERMONT 300 300 0.00 42 44 4.76
2018-08-14 13F-HR HighTower Advisors, LLC 66,381 67,747 2.06 9,257 9,933 7.30
2018-08-14 13F-HR Altium Wealth Management Llc 1,624 1,624 0.00 227 239 5.29
2018-08-08 13F-HR KEYBANK NATIONAL ASSOCIATION/OH 57,565 56,400 -2.02 8,041 8,292 3.12
2018-08-07 13F-HR Quantitative Advantage, LLC 101,004 100,280 -0.72 14,109 14,743 4.49
2018-07-25 13F-HR Santori & Peters, Inc. 3,857 4,781 23.96 538 702 30.48
2018-08-13 13F-HR Stratos Wealth Partners, LTD. 337 0 -100.00 47 0 -100.00
2018-08-14 13F-HR Goelzer Investment Management, Inc. 8,614 5,214 -39.47 1,203 767 -36.24
2018-08-01 13F-HR FIRST MANHATTAN CO 645 2,060 219.38 90 302 235.56
2018-07-20 13F-HR Creative Planning 1,577 1,577 0.00 220 232 5.45
2018-08-08 13F-HR US BANCORP \DE\ 755 755 0.00 105 111 5.71
2017-01-13 13F-HR MetLife Securities, Inc 7,712 8,110 5.16 824 872 5.83
2018-08-09 13F-HR Timber Hill LLC 3,134 0 -100.00 438 0 -100.00
2018-08-06 13F-HR Newport Wealth Strategies, Inc. 11,595 5,440 -53.08 1,620 800 -50.62
2018-07-19 13F-HR HUNTINGTON NATIONAL BANK 391 55 31 -43.64
2018-07-19 13F-HR Pfg Advisors 2,061 2,959 43.57 288 435 51.04
2018-08-13 13F-HR Sequoia Financial Advisors, LLC 241,626 233,709 -3.28 33,753 34,360 1.80
2018-07-19 13F-HR Carroll Financial Associates, Inc. 255 255 0.00 35 37 5.71
2018-08-10 13F-HR BROWN ADVISORY INC 4,960 4,960 0.00 693 729 5.19
2018-08-13 13F-HR Trust Asset Management LLC 20,640 3,034
2018-08-14 13F-HR F3logic, Llc 8,251 4,743 -42.52 1,155 701 -39.31
2018-08-07 13F-HR Good Life Advisors, LLC 10,096 10,825 7.22 1,376 1,592 15.70
2018-07-30 13F-HR/A Virtu Financial LLC 2,742 5,640 105.69 383 829 116.45
2018-02-15 13F-HR Bb&t Investment Services, Inc. 60 60 0.00 8 8 0.00
2018-07-26 13F-HR Advisornet Financial, Inc 5,718 5,718 0.00 799 841 5.26
2018-08-09 13F-HR BlackRock Inc. 5 5 0.00 1 1 0.00
2018-08-07 13F-HR IFP Advisors, Inc 2,125 2,125 0.00 297 312 5.05
2018-08-08 13F-HR Financial Advocates Investment Management 2,644 2,634 -0.38 369 389 5.42
2018-08-01 13F-HR Carmichael Hill & Associates, Inc. 4,827 4,912 1.76 674 722 7.12
2018-07-05 13F-HR AMERICAN NATIONAL BANK 4,452 4,452 0.00 622 655 5.31
2018-04-18 13F-HR/A FNY Partners Fund LP 150 20
2018-07-30 13F-HR Clearshares Llc 18,741 18,252 -2.61 2,575 2,679 4.04
2018-08-07 13F-HR PHH Investments, Ltd. 4,161 3,400 -18.29 581 500 -13.94
2018-08-10 13F-HR Midwest Professional Planners, Ltd. 87 87 0.00 12 13 8.33
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 4,698 4,698 0.00 604 604 0.00
2018-08-02 13F-HR Chevy Chase Trust Holdings, Inc. 6,000 6,000 0.00 838 882 5.25
2018-08-14 13F-HR MORGAN STANLEY 371,345 366,238 -1.38 51,874 53,844 3.80
2018-08-14 13F-HR Centaurus Financial, Inc. 4,719 961 -79.64 659 141 -78.60
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 104,662 97,340 -7.00 14,620 14,311 -2.11
2018-08-14 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 952 139,963
2018-08-13 13F-HR BOKF, NA 4,919 5,083 3.33 687 747 8.73
2018-08-13 13F-HR CAPTRUST FINANCIAL ADVISORS 21,557 20,908 -3.01 2,937 3,083 4.97
2018-08-08 13F-HR Private Ocean, LLC 1,505 606 -59.73 210 89 -57.62
2018-08-14 13F-HR Invesco Ltd. 19,668 19,018 -3.30 2,747 2,796 1.78
2018-08-08 13F-HR Brand Asset Management Group, Inc. 30,083 4,423
2018-08-14 13F-HR AMERIPRISE FINANCIAL INC 83,557 89,963 7.67 11,665 13,226 13.38
2018-08-13 13F-HR MML INVESTORS SERVICES, LLC 28,867 33,101 14.67 4,032 4,867 20.71
2018-08-13 13F-HR BLAIR WILLIAM & CO/IL 3,683 3,683 0.00 514 541 5.25
2018-08-14 13F-HR FLAGSHIP HARBOR ADVISORS, LLC 1,200 176
2018-07-27 13F-HR Citizens Financial Group Inc/RI 55 168 205.45 8 25 212.50
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 48,603 51,945 6.88 6,790 7,638 12.49
2018-08-14 13F-HR SUNTRUST BANKS INC 585,664 558,123 -4.70 81,810 82,054 0.30
2018-08-09 13F-HR Bay Colony Advisory Group, Inc D/b/a Bay Colony Advisors 233 34

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

A Spread of Top-Ranked Growth ETFs Hitting All-Time Highs

2018-08-28 zacks
After a lackluster July, growth stocks seem to have regained their appeal this month. This is especially true given that the S&P 500 Growth Index is up 3.9% so far this month, outpacing the gain of 1.6% for the S&P 500 Value Index. Strong rebound in large-capitalization technology and Internet stocks as well as surging earnings led to investors’ appetite for more risk. Double-digit earnings growth in the second quarter is expected to be the highest quarterly growth pace in almost eight years.

CUSIP: 92206C680